ArticleBMC systems biology2015

From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.

Clémence Chamard-Jovenin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.